The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

Stopped The study was terminated prior to completing the planned cohorts and analysis because of problems with the infusion set resulting in inadequate insulin delivery

Conditions

• Diabetes Mellitus Type 1

Interventions

• DEVICE: iPhone bionic pancreas
• DEVICE: iLet bionic pancreas
• DRUG: Xeris Xerisol glucagon
• DRUG: Lilly glucagon
• DEVICE: iLet infusion set
• DEVICE: Contact Detach infusion set

Sponsor

Massachusetts General Hospital

Collaborators

• [object Object]